US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

26.27

+1.696.88%

Post-market: 26.500.2300+0.88%19:53 EDT

Volume:6.39M

Turnover:165.58M

Market Cap:7.41B

PE:70.62

High:26.60

Open:24.73

Low:24.32

Close:24.58

52wk High:42.50

52wk Low:14.19

Shares:282.15M

Float Shares:116.00M

Volume Ratio:1.40

T/O Rate:5.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3720

EPS(LYR):-3.2200

ROE:20.13%

ROA:8.77%

PB:12.53

PE(LYR):-8.16

Loading ...

Overview Company News Filings

Caris Life Sciences launches USD 100 million share buyback program

Caris Life Sciences - Company Expects to Fund Repurchase Program From Available Cash and Cash Equivalents

THOMSON REUTERS

Caris Life Sciences Announces Share Repurchase Program

THOMSON REUTERS

Caris Life Sciences Coverage Assumed by Wolfe Research at Peer Perform

Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research

Caris studies MSH3 loss impact on immune checkpoint outcomes across cancers at ASCO 2026

Cloud AI Update - CAI Boosts Multicloud Integration With AWS And Microsoft Partnerships

Simply Wall St.

CAI Corp Reports Unaudited Net Asset Value of HK$0.14 Per Share

Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)

Caris Life Sciences Director Makes Bold Insider Move With Major Stock Purchase

Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating

Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95

Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler

Caris Life Sciences announces publication of study on measuring TMB using WES

Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels

Guggenheim Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)

Caris Life Sciences submits application to NYSDOH for Caris Assure testing

Caris Life Sciences Submits Application for Molecular Profiling Test in New York State

MT Newswires Live

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization

THOMSON REUTERS

Caris submits NY health department review application for Caris Assure blood test authorization

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CAI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":26.27,"timestamp":1787342400000,"preClose":24.58,"halted":0,"volume":6389323,"hourTrading":{"tag":"盘后","latestPrice":26.5,"preClose":26.27,"latestTime":"19:53 EDT","volume":52912,"amount":1390891.1167,"timestamp":1787356418341,"change":0.23,"changeRate":0.008755,"amplitude":0.023982},"delay":0,"changeRate":0.06875508543531332,"floatShares":115999999,"shares":282146923,"eps":0.372,"marketStatus":"Market Closed","change":1.69,"latestTime":"08-21 16:00:00 EDT","open":24.73,"high":26.6,"low":24.32,"amount":165579567.50724298,"amplitude":0.092758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.372,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":24.58,"preHourTrading":{"tag":"盘前","latestPrice":24.71,"preClose":24.58,"latestTime":"09:26 EDT","volume":1358,"amount":33738.672114,"timestamp":1787318762450,"change":0.13,"changeRate":0.005289,"amplitude":0.016444},"postHourTrading":{"tag":"盘后","latestPrice":26.5,"preClose":26.27,"latestTime":"19:53 EDT","volume":52912,"amount":1390891.1167,"timestamp":1787356418341,"change":0.23,"changeRate":0.008755,"amplitude":0.023982},"volumeRatio":1.3992123548261108,"impliedVol":0.7713,"impliedVolPercentile":0.5896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","floatShares":115999999,"roa":"8.77%","roe":"20.13%","lyrEps":-3.22,"volumeRatio":1.3992123548261108,"shares":282146923,"dividePrice":0,"high":26.6,"amplitude":0.092758,"preClose":24.58,"low":24.32,"week52Low":14.19,"pbRate":"12.53","psRate":"7.49","week52High":42.5,"institutionHeld":0,"latestPrice":26.27,"eps":0.372,"divideRate":0,"volume":6389323,"delay":0,"ttmEps":0.372,"open":24.73,"prevYearClose":26.98,"prevWeekClose":21.8,"prevMonthClose":15.67,"prevQuarterClose":17.82,"fiveDayClose":21.8,"twentyDayClose":15.52,"sixtyDayClose":15.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"CAI","fiscalQuarterEnding":"2026/06","expectedEps":-0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2026-05-07","symbol":"CAI","fiscalQuarterEnding":"2026/03","expectedEps":-0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2026-02-26","symbol":"CAI","fiscalQuarterEnding":"2025/12","expectedEps":0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2026-01-12","symbol":"CAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CAI","date":"2026-08-21","current":70.61828,"percent":0.822674,"low":-88.150592,"twenty":-40.929651,"median":-30.496198,"eighty":58.231247,"high":165.024421,"avg":-0.696919,"sd":71.195108,"marketCap":6946189671},"quantilePoints":[{"date":"2021-08-27","current":9.375312,"twenty":3.945116,"median":11.370572,"eighty":29.049822,"marketCap":969144784},{"date":"2021-09-03","current":9.390407,"twenty":4.024071,"median":11.370572,"eighty":29.049822,"marketCap":970705124},{"date":"2021-09-10","current":9.365249,"twenty":4.076458,"median":11.370572,"eighty":29.049822,"marketCap":968104557},{"date":"2021-09-17","current":9.368604,"twenty":4.110509,"median":11.370572,"eighty":29.049822,"marketCap":968451299},{"date":"2021-09-24","current":9.368604,"twenty":4.156375,"median":11.370572,"eighty":29.049822,"marketCap":968451299},{"date":"2021-10-01","current":9.376989,"twenty":4.213229,"median":11.370724,"eighty":29.050072,"marketCap":969318155},{"date":"2021-10-07","current":9.380344,"twenty":4.238981,"median":11.370724,"eighty":29.050072,"marketCap":969664897},{"date":"2021-10-15","current":9.378667,"twenty":4.266668,"median":11.380332,"eighty":29.050823,"marketCap":969491526},{"date":"2021-10-22","current":9.378667,"twenty":4.284214,"median":11.383933,"eighty":29.120677,"marketCap":969491526},{"date":"2021-10-29","current":9.382021,"twenty":4.305342,"median":11.383933,"eighty":29.120677,"marketCap":969838269},{"date":"2021-11-05","current":9.383698,"twenty":4.32826,"median":11.383933,"eighty":29.120677,"marketCap":970011640},{"date":"2021-11-09","current":6.915273,"twenty":4.340793,"median":11.383933,"eighty":29.120677,"marketCap":961803774},{"date":"2025-06-20","current":-27.445954,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7736739976},{"date":"2025-06-27","current":-26.374479,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7434701838},{"date":"2025-07-03","current":-26.167427,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7376335954},{"date":"2025-07-11","current":-26.246304,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7398570576},{"date":"2025-07-18","current":-30.845816,"twenty":9.382356,"median":19.818182,"eighty":28.465108,"marketCap":8695126991},{"date":"2025-07-25","current":-29.076014,"twenty":9.380344,"median":19.818182,"eighty":28.465108,"marketCap":8196237652},{"date":"2025-08-01","current":-27.685808,"twenty":9.378667,"median":19.818182,"eighty":28.465108,"marketCap":7804352434},{"date":"2025-08-08","current":-28.188649,"twenty":9.377325,"median":19.778051,"eighty":28.363181,"marketCap":7946098151},{"date":"2025-08-15","current":-37.278729,"twenty":9.37397,"median":15.016779,"eighty":28.059445,"marketCap":10402480346},{"date":"2025-08-22","current":-38.41755,"twenty":9.371958,"median":14.936518,"eighty":27.857377,"marketCap":10720263606},{"date":"2025-08-29","current":-38.528408,"twenty":9.368604,"median":14.909765,"eighty":27.685829,"marketCap":10751198260},{"date":"2025-09-05","current":-36.633734,"twenty":9.365249,"median":14.888362,"eighty":27.527351,"marketCap":10222496907},{"date":"2025-09-12","current":-34.47703,"twenty":9.360553,"median":14.824668,"eighty":27.293717,"marketCap":9620677282},{"date":"2025-09-19","current":-33.690942,"twenty":7.38442,"median":14.763781,"eighty":26.71778,"marketCap":9401322465},{"date":"2025-09-26","current":-29.962061,"twenty":-25.851919,"median":14.718778,"eighty":26.293958,"marketCap":8360793206},{"date":"2025-10-03","current":-29.941905,"twenty":-26.165455,"median":11.559155,"eighty":25.35941,"marketCap":8355168724},{"date":"2025-10-10","current":-31.504003,"twenty":-26.421805,"median":11.424439,"eighty":24.232627,"marketCap":8791066116},{"date":"2025-10-17","current":-32.199389,"twenty":-27.275648,"median":11.239535,"eighty":23.200759,"marketCap":8985110761},{"date":"2025-10-24","current":-31.907126,"twenty":-27.85145,"median":10.925198,"eighty":22.717001,"marketCap":8903555765},{"date":"2025-10-31","current":-31.413301,"twenty":-29.076014,"median":10.711237,"eighty":22.474875,"marketCap":8765755945},{"date":"2025-11-07","current":-37.133331,"twenty":-29.570316,"median":10.518408,"eighty":22.474875,"marketCap":6943635775},{"date":"2025-11-14","current":-36.66558,"twenty":-29.872671,"median":10.079921,"eighty":22.474875,"marketCap":6856170228},{"date":"2025-11-21","current":-36.258185,"twenty":-30.266418,"median":9.392084,"eighty":22.474875,"marketCap":6779990559},{"date":"2025-11-28","current":-38.521493,"twenty":-30.494182,"median":9.38873,"eighty":22.474875,"marketCap":7203210944},{"date":"2025-12-05","current":-42.731244,"twenty":-30.709853,"median":9.383698,"eighty":22.390599,"marketCap":7990400859},{"date":"2025-12-12","current":-40.045453,"twenty":-31.411285,"median":9.382021,"eighty":21.98126,"marketCap":7488179336},{"date":"2025-12-19","current":-42.037163,"twenty":-31.770064,"median":9.380344,"eighty":21.917049,"marketCap":7860613274},{"date":"2025-12-26","current":-42.610535,"twenty":-32.023314,"median":9.378667,"eighty":21.917049,"marketCap":7967829105},{"date":"2026-01-02","current":-40.709356,"twenty":-33.019743,"median":9.376989,"eighty":21.917049,"marketCap":7612323982},{"date":"2026-01-09","current":-42.625623,"twenty":-33.660707,"median":9.375312,"eighty":21.911699,"marketCap":7970650574},{"date":"2026-01-16","current":-40.920598,"twenty":-34.325859,"median":9.371958,"eighty":14.957921,"marketCap":7651824551},{"date":"2026-01-23","current":-38.55167,"twenty":-35.122025,"median":9.368604,"eighty":14.936518,"marketCap":7208853882},{"date":"2026-01-30","current":-38.023565,"twenty":-36.062032,"median":9.366927,"eighty":14.901739,"marketCap":7110102459},{"date":"2026-02-06","current":-32.063522,"twenty":-36.001677,"median":9.365249,"eighty":14.891037,"marketCap":5995622113},{"date":"2026-02-13","current":-31.158199,"twenty":-36.001677,"median":9.358541,"eighty":14.824668,"marketCap":5826333959},{"date":"2026-02-20","current":-31.459973,"twenty":-36.001677,"median":6.916509,"eighty":14.791194,"marketCap":5882763344},{"date":"2026-02-27","current":-79.83495,"twenty":-36.095748,"median":-25.920936,"eighty":14.746309,"marketCap":5435802106},{"date":"2026-03-06","current":-79.767155,"twenty":-36.689445,"median":-26.167427,"eighty":11.649494,"marketCap":5431186043},{"date":"2026-03-13","current":-73.417324,"twenty":-37.230355,"median":-26.433637,"eighty":11.50157,"marketCap":4998838767},{"date":"2026-03-20","current":-78.065566,"twenty":-37.948121,"median":-27.000565,"eighty":11.33727,"marketCap":5315328276},{"date":"2026-03-27","current":-76.073463,"twenty":-38.51833,"median":-27.544452,"eighty":11.081046,"marketCap":5179689915},{"date":"2026-04-02","current":-79.393635,"twenty":-38.55167,"median":-28.040754,"eighty":10.896141,"marketCap":5405753850},{"date":"2026-04-10","current":-79.684151,"twenty":-38.689657,"median":-29.080944,"eighty":10.700671,"marketCap":5425534444},{"date":"2026-04-17","current":-84.66441,"twenty":-39.396638,"median":-29.538348,"eighty":10.447088,"marketCap":5764630347},{"date":"2026-04-24","current":-82.156794,"twenty":-39.864388,"median":-29.869713,"eighty":9.998035,"marketCap":5593891765},{"date":"2026-05-01","current":-78.877164,"twenty":-40.407582,"median":-30.254324,"eighty":9.392084,"marketCap":5370588355},{"date":"2026-05-08","current":165.024421,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5608024892},{"date":"2026-05-15","current":126.854033,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4310880598},{"date":"2026-05-22","current":132.593658,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4505930278},{"date":"2026-05-29","current":138.666015,"twenty":-40.929651,"median":-30.496198,"eighty":9.387052,"marketCap":4712287185},{"date":"2026-06-05","current":143.740176,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4884722409},{"date":"2026-06-12","current":149.72935,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5088252510},{"date":"2026-06-18","current":148.564789,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5048677212},{"date":"2026-06-26","current":155.552158,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5286128996},{"date":"2026-07-02","current":155.968073,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5300263031},{"date":"2026-07-10","current":148.647972,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":5051504019},{"date":"2026-07-17","current":137.085538,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4658577853},{"date":"2026-07-24","current":130.181352,"twenty":-40.920598,"median":-30.491159,"eighty":9.387052,"marketCap":4423952876},{"date":"2026-07-31","current":133.841403,"twenty":-40.929651,"median":-30.496198,"eighty":9.387052,"marketCap":4548332382},{"date":"2026-08-07","current":53.756202,"twenty":-40.929651,"median":-30.496198,"eighty":9.389065,"marketCap":5651658300},{"date":"2026-08-14","current":59.618217,"twenty":-40.929651,"median":-30.496198,"eighty":9.397451,"marketCap":6267961225},{"date":"2026-08-21","current":66.069241,"twenty":-40.929651,"median":-30.496198,"eighty":58.231247,"marketCap":6946189671}],"updateTime":1787503348171},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CAI\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641484308","title":"Caris Life Sciences launches USD 100 million share buyback program","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484308","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484308?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:31","pubTimestamp":1780921907,"startTime":"0","endTime":"0","summary":"Caris Life Sciences launched a share repurchase program of up to USD 100 million for its outstanding common stock.Buybacks may be executed in the open market or via privately negotiated transactions, including Rule 10b5-1 trading plans.The program has no expiration date. It can be modified, suspended, or ended at the board’s discretion.Repurchases are expected to be funded from available cash and cash equivalents.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on June 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDLcdJ7JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641843494","title":"Caris Life Sciences - Company Expects to Fund Repurchase Program From Available Cash and Cash Equivalents","url":"https://stock-news.laohu8.com/highlight/detail?id=2641843494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641843494?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:30","pubTimestamp":1780921802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA1C88ZK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAI","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641313484","title":"Caris Life Sciences Announces Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2641313484","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641313484?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:30","pubTimestamp":1780921802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA1C88ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAI","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948406","title":"Caris Life Sciences Coverage Assumed by Wolfe Research at Peer Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948406?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:26","pubTimestamp":1780403160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2026 08:26 ET (12:26 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962669","title":"Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962669?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:23","pubTimestamp":1780345439,"startTime":"0","endTime":"0","summary":"Wolfe Research analyst Mike Polark downgraded Caris Life Sciences (CAI) to Peer Perform from Outperform with no price target as the analyst assumed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-assumed-at-peer-perform-from-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-assumed-at-peer-perform-from-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637406312","title":"Caris studies MSH3 loss impact on immune checkpoint outcomes across cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637406312","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637406312?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:25","pubTimestamp":1779456354,"startTime":"0","endTime":"0","summary":"Caris Life Sciences outlined 32 retrospective, real-world studies slated for presentation at the 2026 ASCO Annual Meeting in Chicago on May 29–June 2, including one rapid oral session on MSH3 loss-of-function alterations in patients treated with immune checkpoint blockade across cancer types.One Caris-led analysis links genetic ancestry to ultraviolet-related mutational patterns in melanoma, positioning the signal as a potential way to refine immunotherapy response assessment beyond standard mutation-based approaches.A separate Caris-led study identifies ESR1 amplification in breast cancer as a distinct genomic subtype tied to poorer outcomes and reduced benefit from CDK4/6 inhibitor therapy, a finding that could influence patient stratification in a major commercial treatment class.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for info","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL9nQl1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311213","title":"Cloud AI Update - CAI Boosts Multicloud Integration With AWS And Microsoft Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311213","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637311213?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:08","pubTimestamp":1779451730,"startTime":"0","endTime":"0","summary":"CAI, a global services firm, has announced strategic partnerships with Amazon Web Services (AWS) and Microsoft to enhance multicloud integration, aiming to support public sector and enterprise clients in modernizing their IT infrastructure. By collaborating with Anthropic, Databricks, and LMNTRIX, CAI seeks to deliver a comprehensive cloud solution that integrates security and AI capabilities across AWS and Azure environments. This multicloud strategy is designed to help organizations avoid...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/21835-main-header/1756191612247","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/21835-main-header/1756191612247"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-msft/microsoft/news/cloud-ai-update-cai-boosts-multicloud-integration-with-aws-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-msft/microsoft/news/cloud-ai-update-cai-boosts-multicloud-integration-with-aws-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635846774","title":"CAI Corp Reports Unaudited Net Asset Value of HK$0.14 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2635846774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635846774?lang=en_us&edition=fundamental","pubTime":"2026-05-15 12:08","pubTimestamp":1778818111,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has provided an announcement. CAI Corp, a Cayman Islands-incorporated company listed on the Hong Kong St...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-of-hk0-14-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-of-hk0-14-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794420","title":"Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635794420?lang=en_us&edition=fundamental","pubTime":"2026-05-14 16:20","pubTimestamp":1778746835,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crispr Therapeutics AG (CRSP) and Caris Life Science...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-caris-life-sciences-inc-cai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-caris-life-sciences-inc-cai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","BK4588","BK4139","LU0029874061.USD","BK4210","BK4611","BK4137","BK4104","LU1861558580.USD","BK4581","BLSG","LU0128526141.USD","BK4585","BLSX","CRSP","LU1861559042.SGD","XBI","BK4112","LABU","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635220266","title":"Caris Life Sciences Director Makes Bold Insider Move With Major Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2635220266","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635220266?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:12","pubTimestamp":1778638358,"startTime":"0","endTime":"0","summary":"New insider activity at Caris Life Sciences, Inc. ( ($CAI) ) has taken place on May 12, 2026. Director Jeff L Vacirca has demonstrated confidence i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/caris-life-sciences-director-makes-bold-insider-move-with-major-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/caris-life-sciences-director-makes-bold-insider-move-with-major-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145960259","title":"Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1145960259","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145960259?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:59","pubTimestamp":1778594347,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634194712","title":"Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2634194712","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634194712?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:23","pubTimestamp":1778588593,"startTime":"0","endTime":"0","summary":"Caris Life Sciences director Jeff L. Vacirca reported a purchase of 31,050 common shares at USD 16.15 per share.Directly held stake rose to 49,671 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL1H22bJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215754","title":"Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215754?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:31","pubTimestamp":1778585477,"startTime":"0","endTime":"0","summary":"In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Caris Life Sciences, Inc., with a price target of $21.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/caris-life-sciences-inc-cai-gets-a-hold-from-piper-sandler-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/caris-life-sciences-inc-cai-gets-a-hold-from-piper-sandler-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634471239","title":"Caris Life Sciences announces publication of study on measuring TMB using WES","url":"https://stock-news.laohu8.com/highlight/detail?id=2634471239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634471239?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:55","pubTimestamp":1778522147,"startTime":"0","endTime":"0","summary":"Caris Life Science has published a study in Cancer Immunology, Immunotherapy demonstrating that measuring tumor mutational burden using ultra-deep ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-announces-publication-of-study-on-measuring-tmb-using-wes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-announces-publication-of-study-on-measuring-tmb-using-wes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139","WES","TMB","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634323519","title":"Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels","url":"https://stock-news.laohu8.com/highlight/detail?id=2634323519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634323519?lang=en_us&edition=fundamental","pubTime":"2026-05-12 00:15","pubTimestamp":1778516124,"startTime":"0","endTime":"0","summary":"Caris Life Sciences published a study in Cancer Immunology, Immunotherapy showing whole exome sequencing-based measurement of tumor mutational burden better identified patients likely to benefit from pembrolizumab than estimates derived from targeted gene panels.Findings were published with no separate conference presentation disclosed.Analysis of 26,756 pembrolizumab-treated patients found targeted panels sometimes misclassified patients, which could shift immunotherapy eligibility decisions.In cases where panel estimates diverged from whole exome results, whole exome-based assessment aligned more closely with improved survival outcomes.Results support broader adoption of whole exome sequencing in therapy selection, reinforcing commercial positioning of its FDA-cleared MI Cancer Seek assay that reports tumor mutational burden.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL5lHptV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634286923","title":"Guggenheim Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634286923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634286923?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500803,"startTime":"0","endTime":"0","summary":"Guggenheim analyst reiterated a Buy rating on Caris Life Sciences, Inc. today and set a price target of $36.00. In addition to Guggenheim, Caris Li...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-caris-life-sciences-inc-cai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-caris-life-sciences-inc-cai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634498431","title":"Caris Life Sciences submits application to NYSDOH for Caris Assure testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2634498431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634498431?lang=en_us&edition=fundamental","pubTime":"2026-05-09 07:01","pubTimestamp":1778281266,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) announced that it has submitted an application to the New York State Department of Health Clinical Laboratory Evaluation ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-submits-application-to-nysdoh-for-caris-assure-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-submits-application-to-nysdoh-for-caris-assure-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","LU0061475181.USD","BK4588","IE0034235188.USD","IE00B3QW5Z07.USD","LU1894683264.USD","STT","LU1894683348.USD","BK4104","BK4139","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU1883839398.USD","CAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634246280","title":"Caris Life Sciences Submits Application for Molecular Profiling Test in New York State","url":"https://stock-news.laohu8.com/highlight/detail?id=2634246280","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634246280?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:25","pubTimestamp":1778271956,"startTime":"0","endTime":"0","summary":"Caris Life Sciences  said late Friday it submitted an application to the New York State Department of Health's Clinical Laboratory Evaluation program, seeking authorization for its blood-based Caris Assure molecular profiling test.The submission starts the formal review process required by New York State for clinical laboratories seeking to conduct testing on specimens collected from New York patients, according to a statement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4104","BK4585","CAI","IE00B64PRP62.GBP","LU0061475181.USD","LU1894683264.USD","STT","BK4139","BK4135","BK7104","IE00B3QW5Z07.USD","LU1883839398.USD","BK4588","IE0034235188.USD","IE00BGHQF748.EUR","LU1894683348.USD","CAI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634464646","title":"Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2634464646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634464646?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:07","pubTimestamp":1778270872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nFWN41L122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CAI","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634615464","title":"Caris submits NY health department review application for Caris Assure blood test authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2634615464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634615464?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:06","pubTimestamp":1778270799,"startTime":"0","endTime":"0","summary":"Caris Life Sciences submitted Caris Assure blood-based molecular profiling test to New York State Department of Health Clinical Laboratory Evaluation Program for authorization to test specimens from New York.Review will be run through Wadsworth Center, covering validation, quality systems, personnel, and regulatory compliance.No determination yet; Caris Assure cannot be used on New York-origin specimens unless CLEP authorization is granted.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL1XhpXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":139,"code":"91000000","status":"200"}]}}